Article
Emergence of Erythromycin Resistant Invasive Group A <i>Streptococcus</i> in West Virginia, United States
2022-08-09
Abstract excerpt
<h4>ABSTRACT</h4> Combination therapy with penicillin and clindamycin has been a mainstay for treatment of invasive group A Streptococcus (iGAS) infections yet increasing macrolide resistance may limit such treatment for strains displaying MLS B phenotypes. The CDC recently reported erythromycin and clindamycin resistance rates for iGAS exceeding 20% in 2017. Here, we investigated 76 iGAS isolates from 66 patie...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 62735519-e472-5298-bd0d-4a378073cab1
- DOI
- 10.1101/2022.08.08.503263
